Literature DB >> 26216452

Increased platelet reactivity in Klinefelter men: something new to consider.

M N D Di Minno1,2, D Esposito3, A Di Minno2, G Accardo3, G Lupoli1, A Cittadini4, D Giugliano5, D Pasquali3.   

Abstract

Patients with Klinefelter syndrome (KS) exhibit an increased cardiovascular risk, but underlying mechanisms are largely unknown. The present cross-sectional study has been conducted to evaluate platelet reactivity and the expression of platelet activation markers (8-iso-prostaglandin F2α[8-iso-PGF2α] and 11-dehydro-thromboxane-B₂[11-dehydro-TXB2]) in KS patients and healthy controls. Twenty-three consecutive KS patients under testosterone replacement therapy have been included as case group and 46 age-matched healthy males recruited among hospital staff served as controls. Light transmission aggregometry was performed in both cases and controls and maximal platelet aggregation (max-A%) was defined as maximal light transmittance reached within 5 min after the addition of 0.2 or 0.4 mm arachidonic acid (AA). A ≥ 50% irreversible light transmittance (LT-50%) following platelet stimulation defined an adequate platelet aggregation and AC-50% was defined as the minimal agonist concentration needed to achieve LT-50%. The AC-50% was 0.26 mm AA for KS and 0.36 mm for controls (p < 0.001). Whereas AA (0.2 mm) induced LT-50% in 69.6% of KS and in 15.2% of controls (p < 0.001), the stimulation with AA (0.4 mm) determined LT-50% in all cases and controls. However, max-A% was higher in KS than in controls both after AA (0.2 mm) (65.61% vs. 46.30%, p = 0.002,) and after AA (0.4 mm) (96.43% vs. 81.04%, p < 0.001). 8-iso-PGF2α and 11-dehydro-TXB2 were higher in KS than in controls (446.54 pg/mg creatinine vs. 230.00 pg/mg creatinine, p < 0.001 and 1278.36 pg/mg creatinine vs. 595.08 pg/mg creatinine, p = 0.001, respectively) and AC-50% inversely correlated with 8-iso-PGF2α (ρ = -0.548, p < 0.001) and with 11-dehydro-TXB2 (ρ = -0.523, p < 0.001). In a linear regression model, KS independently predicted a lower AC-50% (β = -0.597, p < 0.001) and higher levels of 8-iso-PGF2α (β = 0.709, p < 0.001) and 11-dehydro-TXB2 (β = 0.605, p < 0.001). In contrast, no correlation has been found between max-A%, testosterone and estradiol levels in KS. We observed increased platelet reactivity in KS. This might, at least in part, explain the increased thrombotic risk associated with this disease.
© 2015 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  Klinefelter syndrome; cardiovascular risk; platelet hyper-reactivity; testosterone

Mesh:

Substances:

Year:  2015        PMID: 26216452     DOI: 10.1111/andr.12080

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  5 in total

Review 1.  Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders.

Authors:  A E Calogero; V A Giagulli; L M Mongioì; V Triggiani; A F Radicioni; E A Jannini; D Pasquali
Journal:  J Endocrinol Invest       Date:  2017-03-03       Impact factor: 4.256

2.  Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk.

Authors:  Simon Chang; Christian Fynbo Christiansen; Anders Bojesen; Svend Juul; Anna-Marie B Münster; Claus H Gravholt
Journal:  Endocr Connect       Date:  2020-01       Impact factor: 3.335

Review 3.  Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Authors:  Baris Gencer; Marco Bonomi; Maria Pia Adorni; Cesare R Sirtori; François Mach; Massimiliano Ruscica
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514

4.  Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies.

Authors:  M Fabrazzo; G Accardo; I Abbondandolo; G Goglia; D Esposito; G Sampogna; F Catapano; D Giugliano; D Pasquali
Journal:  J Endocrinol Invest       Date:  2020-08-31       Impact factor: 4.256

5.  Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry.

Authors:  Rita Indirli; Emanuele Ferrante; Erica Scalambrino; Eriselda Profka; Marigrazia Clerici; Tommaso Lettera; Andreea Liliana Serban; Walter Vena; Alessandro Pizzocaro; Marco Bonomi; Biagio Cangiano; Giulia Carosi; Gherardo Mazziotti; Luca Persani; Andrea Lania; Maura Arosio; Flora Peyvandi; Giovanna Mantovani; Armando Tripodi
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.